Syndicated Research Studies

The global heparin market was valued at approximately USD 7.56 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 2.7% from 2024 to 2030. A significant driver behind this market expansion is the rising prevalence of chronic diseases. According to a WHO article published in September 2023, noncommunicable diseases (NCDs), which include chronic diseases, are responsible for approximately 41 million deaths each year. Of these, cardiovascular diseases (CVDs) account for 17.9 million deaths, cancer causes 9.3 million deaths, chronic respiratory diseases contribute to 4.1 million deaths, and diabetes, including complications from diabetes-related kidney diseases, leads to an additional 2 million deaths. This growing burden of chronic conditions is expected to boost the demand for heparin, a critical anticoagulant used in treating various health conditions. In addition to this, factors such as the increasing demand for whole blood and blood component transfusi...

The global heparin market was valued at approximately USD 7.56 billion in 2023 and is projected to experience a compound annual growth rate (CAGR) of 2.7% from 2024 to 2030. A significant factor driving this market growth is the rising prevalence of chronic diseases. According to a World Health Organization (WHO) report released in September 2023, noncommunicable diseases (NCDs), often referred to as chronic diseases, are responsible for approximately 41 million deaths each year. Within this category, cardiovascular diseases (CVDs) account for 17.9 million fatalities, while cancer is linked to 9.3 million deaths. Additionally, chronic respiratory diseases contribute to 4.1 million deaths, and diabetes, including complications associated with kidney disease, leads to around 2 million deaths. The increasing demand for whole blood and blood component transfusions, a growing elderly population, and heightened needs for plasma in the pharmaceutical industry are all expected to further stimu...

The global heparin market was valued at approximately USD 7.56 billion in 2023 and is anticipated to experience a compound annual growth rate (CAGR) of 2.7% from 2024 to 2030. A significant driver of this market growth is the rising incidence of chronic diseases. According to a World Health Organization (WHO) report published in September 2023, noncommunicable diseases (NCDs), commonly referred to as chronic diseases, are responsible for around 41 million fatalities each year. Among these, cardiovascular diseases (CVDs) account for 17.9 million deaths, while cancer is linked to 9.3 million deaths. Additionally, chronic respiratory diseases contribute to 4.1 million deaths, and diabetes, including complications related to kidney disease, results in 2 million deaths. The increasing need for whole blood and blood component transfusions, a growing elderly population, and the high demand for plasma in the pharmaceutical sector are all expected to further propel the growth of the heparin mar...